Common Stock, Shares, Outstanding of NEUROONE MEDICAL TECHNOLOGIES Corp from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 50,413,148, a 63% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 50,413,148 +19,571,318 +63% 31 Dec 2025 10-Q 17 Feb 2026 2026 Q1
Q3 2025 50,006,464 +19,189,965 +62% 30 Sep 2025 10-Q 17 Feb 2026 2026 Q1
Q2 2025 49,824,780 +21,978,058 +79% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 31,385,526 +5,063,776 +19% 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 30,841,830 +6,010,740 +24% 31 Dec 2024 10-Q 12 Feb 2025 2025 Q1
Q3 2024 30,816,499 +6,887,554 +29% 30 Sep 2024 10-K 17 Dec 2025 2025 FY
Q2 2024 27,846,722 +9,984,560 +56% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 26,321,750 +9,434,012 +56% 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 24,831,090 +8,592,626 +53% 31 Dec 2023 10-Q 13 Feb 2024 2024 Q1
Q3 2023 23,928,945 +7,712,405 +48% 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 17,862,162 +1,667,546 +10% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 16,887,738 +696,569 +4.3% 31 Mar 2023 10-Q 12 May 2023 2023 Q2
Q4 2022 16,238,464 +50,742 +0.31% 31 Dec 2022 10-Q 13 Feb 2023 2023 Q1
Q3 2022 16,216,540 +4,206,521 +35% 30 Sep 2022 10-K 15 Dec 2023 2023 FY
Q2 2022 16,194,616 +4,213,236 +35% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 16,191,169 +4,280,852 +36% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 16,187,722 -6,902,329 -30% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 12,010,019 +4,616,382 +62% 30 Sep 2021 10-K 22 Dec 2022 2022 FY
Q2 2021 11,981,380 -6,258,217 -34% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 11,910,317 -2,112,106 -15% 31 Mar 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 23,090,051 +9,354,177 +68% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 7,393,637 -6,100,068 -45% 30 Sep 2020 10-K/A 31 May 2022 2021 FY
Q2 2020 18,239,597 +4,821,832 +36% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q3
Q1 2020 14,022,423 +1,077,909 +8.3% 31 Mar 2020 10-Q 14 May 2020 2020 Q2
Q4 2019 13,735,874 +3,699,369 +37% 31 Dec 2019 10-Q 14 Feb 2020 2020 Q1
Q3 2019 13,493,705 +3,837,200 +40% 30 Sep 2019 10-K 09 Dec 2020 2020 FY
Q2 2019 13,417,765 +5,402,771 +67% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q3
Q1 2019 12,944,514 +5,079,520 +65% 31 Mar 2019 10-Q 10 May 2019 2019 Q2
Q4 2018 10,036,505 +2,171,511 +28% 31 Dec 2018 10-Q 14 Feb 2019 2019 Q1
Q3 2018 9,656,505 +1,791,511 +23% 30 Sep 2018 10-K 20 Dec 2019 2019 FY
Q2 2018 8,014,994 +2,941,994 +58% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 7,864,994 +2,791,994 +55% 31 Mar 2018 10-Q 16 May 2018 2018 Q1
Q4 2017 7,864,994 +2,648,429 +51% 31 Dec 2017 10-KT 18 Mar 2019 2018 FY
Q3 2017 7,864,994 +2,791,994 +55% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 5,073,000 0 0% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 5,073,000 0 0% 31 Mar 2017 10-Q 22 May 2017 2017 Q1
Q4 2016 5,216,565 +143,565 +2.8% 31 Dec 2016 10-K 16 Apr 2018 2017 FY
Q3 2016 5,073,000 0 0% 30 Sep 2016 10-Q 21 Nov 2016 2016 Q3
Q2 2016 5,073,000 0 0% 30 Jun 2016 10-Q 19 Aug 2016 2016 Q2
Q1 2016 5,073,000 0 0% 31 Mar 2016 10-Q 23 May 2016 2016 Q1
Q4 2015 5,073,000 0 0% 31 Dec 2015 10-K 17 Apr 2017 2016 FY
Q3 2015 5,073,000 0 0% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 5,073,000 0 0% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 5,073,000 0 0% 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q4 2014 5,073,000 0 0% 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q3 2014 5,073,000 30 Sep 2014 10-Q 19 Nov 2014 2014 Q3
Q2 2014 5,073,000 30 Jun 2014 10-Q 18 Aug 2014 2014 Q2
Q1 2014 5,073,000 0 0% 31 Mar 2014 10-Q 20 May 2014 2014 Q1
Q4 2013 5,073,000 0 0% 31 Dec 2013 10-K 15 Apr 2015 2014 FY
Q1 2013 5,073,000 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 5,073,000 +573,000 +13% 31 Dec 2012 10-K/A 24 Apr 2014 2013 FY
Q3 2012 5,073,000 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q4 2011 4,500,000 0 0% 31 Dec 2011 10-Q 13 Nov 2012 2012 Q3
Q4 2010 4,500,000 31 Dec 2010 10-K 28 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.